The History Of ADHD Medication Pregnancy
From Shiapedia
ADHD Medication During Pregnancy and Breastfeeding
Women suffering from ADHD have to make a difficult choice regarding whether or not to stop taking ADHD medication during pregnancy and breast-feeding. There aren't many studies regarding how exposure over time may affect a pregnant fetus.
A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological issues such as hearing loss or vision, febrile seizures, or IQ impairment. The authors acknowledge the need for more high-quality research.
Risk/Benefit Analysis
Pregnant women who take ADHD medications must weigh the advantages of taking them against potential risks to the foetus. Doctors don't have the data needed to make unequivocal recommendations but they can provide information on risks and benefits that help pregnant women make informed decisions.
A study published in Molecular Psychiatry concluded that women who were taking ADHD medication during their early pregnancy did not have a higher risk of fetal malformations or structural birth defects. Researchers conducted a large population-based study of case-control to assess the risk of major structural birth defects in babies born to mothers who had taken stimulants during the early stages of pregnancy, as well as those who had not. Pediatric cardiologists, clinical geneticists and other experts examined the cases to confirm that the classification was correct and to reduce any bias.
However, the study had its limitations. In particular, they were unable to separate the effects of the medication from the underlying disorder. This limitation makes it difficult for researchers to determine if the few associations observed between the exposed groups were due to medication use or if they were caused by the presence of comorbidities. In addition the study did not study the long-term outcomes of offspring.
The study revealed that infants whose mothers had taken ADHD medication during pregnancy were at a slightly greater risk of being admitted to the neonatal care unit (NICU) as compared to those whose mothers did not use any medication during pregnancy or had quit taking the medication prior to or during pregnancy. This was due to central nervous system disorders. The increased risk of admission was not influenced by the stimulant medications used during pregnancy.
Women who took stimulant ADHD medications during pregnancy also had a higher likelihood of having caesarean sections or one whose baby scored low on the Apgar scale (less than 7). These risks did not appear to be affected by the type of medication that was used during pregnancy.
Researchers suggest that the small risks associated with the use ADHD medications during early pregnancies may be offset by the greater benefits to both mother and baby from continuing treatment for the woman's condition. Physicians should discuss this with their patients and, where possible, assist them in developing strategies to improve their coping abilities that can lessen the negative impact of her condition on her daily functioning and relationships.
Medication Interactions
As more women than ever before are being diagnosed with ADHD and being treated with medication, the dilemma of whether or not to stop treatment during pregnancy is a question that doctors are having to have to face. These decisions are frequently made without clear and authoritative evidence. Instead, doctors must weigh their own knowledge, the experience of other physicians and the research on the subject.
The issue of risk to infants is difficult to determine. The research on this subject is based on observation rather than controlled studies and the results are conflicting. most common adhd medication adderall uk medications; hangoutshelp.net, studies limit their analysis to live-births, which could underestimate the teratogenic impact leading to terminations or abortions of pregnancy. The study that is discussed in the journal club addresses these shortcomings by analyzing both data on live and deceased births.
The conclusion: While some studies have found an association between ADHD medications and the possibility of certain birth defects, other studies have found no such relationship, and most studies have a neutral or slight negative effect. In the end, a careful risk/benefit assessment must be conducted in every instance.
For many women with does adhd medication work, the decision to discontinue medication is difficult, if not impossible. In a recent article published in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can increase depression and feelings of isolation. A loss of medication may affect the ability to drive safely and to perform work-related tasks which are essential aspects of daily life for people with ADHD.
She suggests that women who can prescribe medication for adhd are not sure whether to continue taking the medication or stop it due to their pregnancy educate family members, coworkers, and friends about the condition, its effects on daily functioning, and the benefits of continuing the current treatment. It can also help women feel confident about her decision. Certain medications can pass through the placenta. If the patient decides to stop taking her ADHD medication while breastfeeding, it is important to be aware that the drug may be transferred to her infant.
Birth Defects Risk
As the use of ADHD drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD) grows, so do concerns about what impact the drugs might have on fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge on this topic. With two massive data sets researchers were able analyze more than 4.3 million pregnancies and see whether stimulant medications increased the risk of birth defects. Researchers discovered that, while the risk overall is low, the first trimester ADHD medication use was associated with slightly higher risk of certain heart defects, like ventriculoseptal defects.
The researchers of the study did not find any association between early medication usage and other congenital anomalies like facial deformities or club feet. The results are in line with previous studies showing an increase, but not significant, in the risk of cardiac malformations among women who started taking ADHD medications prior to the birth of their child. This risk increased in the latter half of pregnancy, when a lot of women decide to stop taking their ADHD medication.
Women who took ADHD medication in the first trimester were more likely to require a caesarean delivery and also have a low Apgar after delivery, and have a baby that needed breathing assistance at birth. The researchers of the study could not remove bias in selection since they limited their study to women without other medical conditions that could have contributed to the findings.
Researchers hope that their study will provide doctors with information when they meet pregnant women. The researchers recommend that, while discussing benefits and risks are crucial, the decision regarding whether or not to stop medication should be based on the severity of each woman's ADHD symptoms and her needs.
The authors also caution that while discontinuing the medications is an alternative, it is not an option to consider due to the high rate of depression and www.jtayl.me other mental health issues among women who are pregnant or recently postpartum. Further, research shows that women who stop taking their medications will have a tough adjustment to life without them once the baby is born.
Nursing
The responsibilities of being a new mom can be overwhelming. Women with ADHD are often faced with a number of difficulties when they must manage their symptoms, attend doctor appointments, prepare for the birth of their child and adjust to new routines. Therefore, many women choose to continue taking their ADHD medications throughout the course of pregnancy.
The risk to a breastfeeding infant is minimal because the majority of stimulant medication is absorbed through breast milk in low amounts. The rate of exposure to medication can vary depending upon the dosage and frequency of administration as well as the time of day. Additionally, different medications are introduced into the baby's system through the gastrointestinal tract, or through breast milk. The effect on the health of a newborn isn't completely comprehended.
Due to the absence of research, some doctors may recommend stopping stimulant drugs during a woman's pregnancy. It is a difficult decision for the woman, who must weigh the benefits of continuing her medication against the risk to the embryo. As long as there is no more information, GPs should ask all pregnant patients about their experience with ADHD and whether they are planning or taking to take medication during the perinatal period.
A growing number of studies have proven that the majority of women are able to safely continue taking their ADHD medication during pregnancy and breastfeeding. This has led to more and more patients choose to do so and in consultation with their physician, they have found that the benefits of keeping their current medication exceed any risk.
Women with ADHD who are planning to nurse should seek advice from a specialist psychiatrist before becoming pregnant. They should review their medications with their prescriber and discuss the advantages and disadvantages of continued treatment, including non-pharmacological strategies. Psychoeducation is also necessary to help pregnant women suffering from adhd sleep medication list recognize the signs and underlying disorder. They should also learn about treatment options and strengthen coping mechanisms. This should include a multidisciplinary approach with the GP as well as obstetricians, psychiatry and obstetricians. Pregnancy counseling should include a discussion of a treatment plan for the mother and the child, monitoring of signs of deterioration and, if needed adjustments to the medication regimen.
